Affiliation:
1. 1Division of Endocrinology, Emory University School of Medicine, Atlanta, GA
2. 2Department of Family and Preventive Medicine, Emory University School of Medicine, Atlanta, GA
3. 3Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, MN
4. 4Division of Community Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, MN
Abstract
OBJECTIVE
We characterized annual trends of severe hypoglycemic and hyperglycemic crises (diabetic ketoacidosis/hyperglycemic hyperosmolar state) in patients with diabetes and end-stage kidney disease (ESKD).
RESEARCH DESIGN AND METHODS
This was a nationwide, retrospective study of adults (≥18 years old) with diabetes/ESKD, from the United States Renal Data System registry, between 2013 and 2017. Primary outcome was annual rates of emergency department visits or hospitalizations for hypoglycemic and hyperglycemic crises, reported as number of events/1,000 person-years. Event rates and risk factors were adjusted for patient age, sex, race/ethnicity, dialysis modality, comorbidities, treatment regimen, and U.S. region.
RESULTS
Among 521,789 adults with diabetes/ESKD (median age 65 years [interquartile range 57–73], 56.1% male, and 46% White), overall adjusted rates of hypoglycemic and hyperglycemic crises were 53.64 and 18.24 per 1,000 person-years, respectively. For both hypoglycemia and hyperglycemia crises, respectively, the risks decreased with age and were lowest in older patients (≥75 vs. 18–44 years old: incidence rate ratio 0.35, 95% CI 0.33–0.37, and 0.03, 0.02–0.03), women (1.09, 1.06–1.12, and 1.44, 1.35–1.54), and those with smoking (1.36, 1.28–1.43, and 1.71, 1.53–1.91), substance abuse (1.27, 1.15–1.42, and 1.53, 1.23–1.9), retinopathy (1.10, 1.06–1.15, and 1.36, 1.26–1.47), and insulin therapy (vs. no therapy; 0.60, 0.59–0.63, and 0.44, 0.39–0.48). For hypoglycemia, specifically, additional risk was conferred by Black race (1.11, 1.08–1.15) and amputation history (1.20, 1.13–1.27).
CONCLUSIONS
In this nationwide study of patients with diabetes/ESKD, hypoglycemic crises were threefold more common than hyperglycemic crises, greatly exceeding national reports in nondialysis patients with chronic kidney disease. Young, Black, and female patients were disproportionately affected.
Publisher
American Diabetes Association
Subject
Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference29 articles.
1. Centers for Disease Control and Prevention
. Chronic Kidney Disease Surveillance System—United States. 2017. Accessed 15 May 2021. Available from https://nccd.cdc.gov/ckd/
2. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease;Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group;Kidney Int,2020
3. Diabetic kidney disease: a report from an ADA Consensus Conference;Tuttle;Diabetes Care,2014
4. Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES 2007-2012;Wu;BMJ Open Diabetes Res Care,2016